Skip to main content
logo
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
209.37
+4.61 (2.25%)
Aug 10, 2026, 4:00 PM EDT - Market closed

Danaher Operating Metrics

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
20.57B20.34B20.13B19.91B19.67B19.39B19.37B17.04B--
Recurring Revenue Growth
4.60%4.93%3.93%16.85%12.76%7.16%3.66%-11.11%--

Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
10.07B9.91B9.94B9.86B9.76B9.71B9.79B9.87B
Diagnostics Growth
3.16%2.06%1.57%-0.08%0.01%-0.20%2.19%0.41%
Biotechnology
7.55B7.48B7.29B7.13B6.98B6.85B6.76B6.65B
Biotechnology Growth
8.08%9.22%7.90%7.22%4.86%0.22%-5.76%-12.93%
Life Sciences
7.49B7.39B7.33B7.28B7.27B7.26B7.33B7.23B
Life Sciences Growth
3.05%1.75%0.07%0.75%1.68%1.21%2.63%0.98%

Operating Income by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.47B2.61B2.65B2.56B2.51B2.51B2.63B2.77B
Diagnostics Growth
-1.71%3.70%0.95%-7.44%-6.69%-1.80%9.10%5.25%
Biotechnology
1.98B1.96B1.86B1.83B1.87B1.74B1.63B1.53B
Biotechnology Growth
5.99%12.41%14.71%19.50%19.87%6.29%-14.88%-29.87%
Life Sciences
1.03B544.00M520.00M560.00M373.00M845.00M879.00M738.00M
Life Sciences Growth
175.34%-35.62%-40.84%-24.12%-63.29%-24.76%-27.30%-45.97%
Other
-347.00M-347.00M-344.00M-340.00M-337.00M-334.00M-326.00M-323.00M

Revenue by Geography

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019
North America
10.29B10.25B10.36B10.45B10.25B10.25B10.30B10.11B--
North America Growth
0.38%0.07%0.59%3.39%-4.30%-8.55%-11.20%-20.23%--
High Growth Markets
7.37B7.11B7.02B6.88B6.87B6.87B6.87B6.88B--
High Growth Markets Growth
7.26%3.48%2.21%-0.04%-5.03%-11.17%-17.03%-21.28%--
Western Europe
6.19B6.16B5.94B5.86B5.66B5.48B5.46B5.31B--
Western Europe Growth
9.34%12.45%8.81%10.41%1.53%-8.17%-14.04%-21.16%--
Other Developed Markets
1.26B1.26B1.25B1.25B1.23B1.23B1.25B1.27B--
Other Developed Markets Growth
2.20%2.44%-0.08%-1.51%-5.03%-7.68%-9.21%-10.53%--

Operating Expense Breakdown

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Oct 1, 2021Sep 30, 2021Jul 2, 2021Jun 30, 2021Apr 2, 2021Mar 31, 2021Dec 31, 2020Oct 2, 2020Sep 30, 2020Jul 3, 2020Jun 30, 2020Apr 3, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
7.95B8.24B8.24B8.23B8.30B7.81B7.76B7.77B--
Selling, General, and Administrative Growth
-4.24%5.47%6.13%5.93%5.66%-4.53%-8.94%-10.43%--
Research and Development
1.62B1.61B1.60B1.60B1.61B1.60B1.58B1.55B--
Research and Development Growth
0.50%0.69%0.88%3.42%1.52%-0.93%-5.21%-9.78%--